Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price1,275.80 INR
Fair value637.90
Ethical score93.8/100
RatingOVERVALUED
Our investment reviews on this name
2026-10-23Read Distribution1,275.80+0.0% to today Markup gives way to Distribution first Distribution read since October
2026-10-16Read Markup1,275.80+0.0% to today ✓Distribution gives way to Markup after a 9% slide in 6 weeks
2026-09-06Read Distribution1,398.90-8.8% to today ✓Accumulation gives way to Distribution with volume flow in agreement
2026-08-06Read Accumulation1,398.90-8.8% to today Markdown gives way to Accumulation with volume flow in agreement
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Nestle India holds its Distribution at $1,275.80. Elevated stress, defensive posture warranted, held for 7 days.
As held on the ledger · 2026-10-15
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 7 days
Price at the screen
$1,275.80
Valuation
75.87 trailing · 57.93 forward price to earnings
Values screen
PASS· score 93.8
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
9.57%
Below 33%
Interest-bearing debt is just 9.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.41%
Below 33%
Cash held in interest-bearing accounts and securities is 0.4% of assets, under the one-third limit.
Pass
Receivables
2.98%
Below 49%
Money owed to the company is 3.0% of assets, under the 49% limit.
Pass
Revenue purity
0.68%
Below 5%
Only 0.7% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Nestle India clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 10%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-24. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NESTLEIND.NS's ethical verdict changes
Today NESTLEIND.NS passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads OVERVALUED: it trades above our $637.90 fair value estimate, 23.80% revenue growth.
Fair value range in INR, drawn from the 2026-10-15 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
At 57.9x forward earnings, the price already runs ahead of the business. It trades 50% above our $637.90 fair value, so you would be buying at a premium, not a discount.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NESTLEIND.NS trades on NSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
2026-10-16Markup · changed$1,275.80-7.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
2026-10-02Distribution$1,372.40-1.9%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
2026-07-18Markdown$1,398.90+0.0%Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (36 analysts) rates it none, with a mean price target of $1473.
2026-07-03Markdown$1,398.90+0.0%Entry 2
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$1,398.90Entry 1
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.